Lung transplantation for cystic fibrosis and bronchiectasis

Seminars in Respiratory and Critical Care Medicine

Volumn 34, Issue 3, 2013, Pages 297-304

  Corris, Paula ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

bronchiectasis; cystic fibrosis; lung transplantation; referral outcomes; specific issues

Indexed keywords

PROKINETIC AGENT;

ACIDEMIA; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; ATYPICAL MYCOBACTERIUM; BACTEREMIA; BACTERIAL GROWTH; BONE DENSITY; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOSTRIDIUM DIFFICILE; CYSTIC FIBROSIS; DIABETES MELLITUS; EMPYEMA; EX VIVO STUDY; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERCAPNIA; HYPOMAGNESEMIA; IN VITRO STUDY; KIDNEY DYSFUNCTION; LUNG FIBROSIS; LUNG FUNCTION; LUNG PERFUSION; LUNG TRANSPLANTATION; MALNUTRITION; MEMBRANE OXYGENATOR; METABOLIC BONE DISEASE; MYCOBACTERIUM ABSCESSUS; NAUSEA; NONINVASIVE VENTILATION; OUTCOME ASSESSMENT; PARANASAL SINUS DISEASE; PATIENT REFERRAL; PLEURECTOMY; PLEURODESIS; PNEUMOTHORAX; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; RESPIRATORY FAILURE; STOMACH FUNDOPLICATION; STOMACH PARESIS; SURVIVAL; TIDAL VOLUME;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRONCHIECTASIS; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; LUNG TRANSPLANTATION; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84879961930     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0033-1348469     Document Type: Article

References (57)

1. Cystic Fibrosis Foundation Patient Registry. Annual data report to the center directors. Bethesda, MD Cystic Fibrosis Foundation: 2008
2. Hertz M. I. The Registry of the International Society for Heart and Lung Transplantation-Introduction to the 2012 annual reports: new leadership, same vision. J Heart Lung Transplant: 2012; 31 10 1045 1051
3. Rosenbluth D. B., Wilson K., Ferkol T., Schuster D. P. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest: 2004; 126 2 412 419
4. Kerem E., Reisman J., Corey M., Canny G. J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med: 1992; 326 18 1187 1191
5. Mayer-Hamblett N., Rosenfeld M., Emerson J., Goss C. H., Aitken M. L. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med: 2002; 166 12, Pt 1 1550 1555
6. Augarten A., Akons H., Aviram M., et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant: 2001; 5 5 339 342
7. Milla C. E., Warwick W. J. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest: 1998; 113 5 1230 1234
8. Liou T. G., Adler F. R., Cahill B. C., et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA: 2001; 286 21 2683 2689
9. Kadikar A., Maurer J., Kesten S. The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant: 1997; 16 3 313 319
10. Venuta F., Rendina E. A., Rocca G. D., et al. Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis. J Thorac Cardiovasc Surg: 2000; 119 4, Pt 1 682 689
11. Tuppin M. P., Paratz J. D., Chang A. T., et al. Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation. J Heart Lung Transplant: 2008; 27 7 729 734
12. Flume P. A., Mogayzel P. J. Jr, Robinson K. A., Rosenblatt R. L., Quittell L., Marshall B. C. Clinical Practice Guidelines for Pulmonary Therapies Committee; Cystic Fibrosis Foundation Pulmonary Therapies Committee Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med: 2010; 182 3 298 306
13. Orens J. B., Estenne M., Arcasoy S., et al. Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant: 2006; 25 7 745 755
14. Egan T., McCullough K., Murray S., et al. Risk factors for death after lung transplantation in the US. J Heart Lung Transplant: 2003; 22 (1, Suppl): S146 S147
15. Haja Mydin H., Corris P. A., Nicholson A., et al. Targeted antibiotic prophylaxis for lung transplantation in cystic fibrosis patients colonised with Pseudomonas aeruginosa using multiple combination bactericidal testing. J Transplant: 2012; 2012 1):135738. doi: 10.11552012/135738. Epub 2012 Jul 16
16. Hadjiliadis D., Steele M. P., Chaparro C., et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant: 2007; 26 8 834 838
17. Chaparro C., Maurer J., Gutierrez C., et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med: 2001; 163 1 43 48
18. Aris R. M., Routh J. C., LiPuma J. J., Heath D. G., Gilligan P. H. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med: 2001; 164 11 2102 2106
19. De Soyza A., McDowell A., Archer L., et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet: 2001; 358 9295 1780 1781
20. Alexander B. D., Petzold E. W., Reller L. B., et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant: 2008; 8 5 1025 1030
21. Murray S., Charbeneau J., Marshall B. C., LiPuma J. J. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med: 2008; 178 4 363 371
22. De Soyza A., Corris P. A. Lung transplantation and the Burkholderia cepacia complex. J Heart Lung Transplant: 2003; 22 9 954 958
23. Levine S. M. Transplant/Immunology Network of the American College of Chest Physicians A survey of clinical practice of lung transplantation in North America. Chest: 2004; 125 4 1224 1238
24. McMenamin J. D., Zaccone T. M., Coenye T., Vandamme P., LiPuma J. J. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest: 2000; 117 6 1661 1665
25. Olivier K. N., Weber D. J., Wallace R. J. Jr., et al. Nontuberculous Mycobacteria in Cystic Fibrosis Study Group Nontuberculous mycobacteria, I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med: 2003; 167 6 828 834
26. Olivier K. N., Weber D. J., Lee J. H., et al. Nontuberculous Mycobacteria in Cystic Fibrosis Study Group Nontuberculous mycobacteria, II: Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med: 2003; 167 6 835 840
27. Chernenko S. M., Humar A., Hutcheon M., et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant: 2006; 25 12 1447 1455
28. Paradowski L. J. Saprophytic fungal infections and lung transplantation-revisited. J Heart Lung Transplant: 1997; 16 5 524 531
29. Helmi M., Love R. B., Welter D., Cornwell R. D., Meyer K. C. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest: 2003; 123 3 800 808
30. Nash E. F., Coonar A. S., Durie P. R., Singer L. G., Keshavjee S., Chaparro C. Retrospective case control study comparing outcomes post-lung transplantationin cystic fibrosis patients with and without cystic fibrosis related liver cirrhosis [abstract]. J Heart Lung Transplant: 2008; 27 2 S138
31. Souilamas R., Guillemain R., Boussaud V., Amrein C., Chevalier P., Fabiani J. N. Combined lung and liver transplantation in patients with cystic fibrosis [abstract]. J Heart Lung Transplant: 2007; 26 2 S127
32. Bravo C., Gispert P., Borro J. M., et al. MITOS Study Group Prevalence and management of gastrointestinal complications in lung transplant patients. Transplant Proc: 2007; 39 7 2409 2412
33. Hadjiliadis D., Duane Davis R., Steele M. P., et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant: 2003; 17 4 363 368
34. Gilljam M., Chaparro C., Tullis E., Chan C., Keshavjee S., Hutcheon M. GI complications after lung transplantation in patients with cystic fibrosis. Chest: 2003; 123 1 37 41
35. Pokorny C. S., Bye P. T., MacLeod C., Selby W. S. Antibiotic-associated colitis and cystic fibrosis. Dig Dis Sci: 1992; 37 9 1464 1468
36. Dallal R. M., Harbrecht B. G., Boujoukas A. J., et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg: 2002; 235 3 363 372
37. Kelly C. P., Pothoulakis C., LaMont J. T. Clostridium difficile colitis. N Engl J Med: 1994; 330 4 257 262
38. Mylonakis E., Ryan E. T., Calderwood S. B. Clostridium difficile-associated diarrhea: a review. Arch Intern Med: 2001; 161 4 525 533
39. Binkovitz L. A., Allen E., Bloom D., et al. Atypical presentation of Clostridium difficile colitis in patients with cystic fibrosis. AJR Am J Roentgenol: 1999; 172 2 517 521
40. Rivlin J., Lerner A., Augarten A., Wilschanski M., Kerem E., Ephros M. A. Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J Pediatr: 1998; 132 1 177 179
41. Aris R. M., Neuringer I. P., Weiner M. A., Egan T. M., Ontjes D. Severe osteoporosis before and after lung transplantation. Chest: 1996; 109 5 1176 1183
42. Spira A., Gutierrez C., Chaparro C., Hutcheon M. A., Chan C. K. Osteoporosis and lung transplantation: a prospective study. Chest: 2000; 117 2 476 481
43. Cahill B. C., O'Rourke M. K., Parker S., Stringham J. C., Karwande S. V., Knecht T. P. Prevention of bone loss and fracture after lung transplantation: a pilot study. Transplantation: 2001; 72 7 1251 1255
44. Milla C. E., Billings J., Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care: 2005; 28 9 2141 2144
45. Dennis C., Caine N., Sharples L., et al. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant: 1993; 12 6, Pt 1 893 902
46. Madill J., Gutierrez C., Grossman J., et al. Toronto Lung Transplant Program Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation. J Heart Lung Transplant: 2001; 20 3 288 296
47. Singer L. G., Brazelton T. R., Doyle R. L., Morris R. E., Theodore J. International Lung Transplant Database Study Group Weight gain after lung transplantation. J Heart Lung Transplant: 2003; 22 8 894 902
48. Robertson J. M., Friedman E. M., Rubin B. K. Nasal and sinus disease in cystic fibrosis. Paediatr Respir Rev: 2008; 9 3 213 219
49. Detterbeck F. C., Egan T. M., Mill M. R. Lung transplantation after previous thoracic surgical procedures. Ann Thorac Surg: 1995; 60 1 139 143
50. Curtis H. J., Bourke S. J., Dark J. H., Corris P. A. Lung transplantation outcome in cystic fibrosis patients with previous pneumothorax. J Heart Lung Transplant: 2005; 24 7 865 869
51. Elizur A., Sweet S. C., Huddleston C. B., et al. Pre-transplant mechanical ventilation increases short-term morbidity and mortality in pediatric patients with cystic fibrosis. J Heart Lung Transplant: 2007; 26 2 127 131
52. Meyer A. L., Goerler H., Gottlieb J., et al. 66: Lung transplantation in patients on invasive ventilation and extracorporeal membrane oxygenation. J Heart Lung Transplant: 2008; 27 (2, Suppl): S83
53. Moran F., Bradley J. M., Jones A. P., Piper A. J. Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev: 2007; 4 CD002769. doi: 10.1002/14651858. Update in: Cochrane Database Syst Rev 2009;(1):CD002769.
54. Orens J. B., Boehler A., de Perrot M., et al. Pulmonary Council, International Society for Heart and Lung Transplantation A review of lung transplant donor acceptability criteria. J Heart Lung Transplant: 2003; 22 11 1183 1200
55. Mascia L., Pasero D., Slutsky A. S., et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA: 2010; 304 23 2620 2627
56. Angel L. F., Levine D. J., Restrepo M. I., et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med: 2006; 174 6 710 716
57. Cypel M., Yeung J. C., Liu M., et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med: 2011; 364 15 1431 1440